Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 00:00 | 24 Apr | Cipla Ltd |
| NSE 05:30 | 01 Jan | Cipla Ltd |
| OPEN | 589.80 |
| PREVIOUS CLOSE | 586.65 |
| VOLUME | 421036 |
| 52-Week high | 615.55 |
| 52-Week low | 356.75 |
| P/E | 20.59 |
| Mkt Cap.(Rs cr) | 48,343 |
| Buy Price | 595.10 |
| Buy Qty | 1.00 |
| Sell Price | 599.60 |
| Sell Qty | 968.00 |
Cipla Ltd. (CIPLA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Guj. Terce Labs. | 8.15 | -31854.93 | -99.97 | 31.03 |
| Colinz Labs | 8.47 | -31854.61 | -99.97 | 7.59 |
| Source Natural | 81.50 | -31781.58 | -99.74 | 12.81 |
| Biofil Chemicals | 13.03 | -31850.05 | -99.96 | 23.13 |
| Roopa Inds. | 11.17 | -31851.91 | -99.96 | 30.15 |
| Artemis Medi. | 162.00 | -31701.08 | -99.49 | 546.50 |
| Tejnaksh Health. | 46.70 | -31816.38 | -99.85 | 13.96 |
| Wintac | 162.00 | -31701.08 | -99.49 | 71.92 |
| N G Inds. | 45.00 | -31818.08 | -99.86 | 17.67 |
| Mercury Labs | 267.50 | -31595.58 | -99.16 | 55.52 |
| Bacil Pharma | 1.80 | -31861.28 | -99.99 | 0.00 |
| Makers Labs. | 45.00 | -31818.08 | -99.86 | 46.63 |
| Zim Labs. | 69.05 | -31794.03 | -99.78 | 331.72 |
| Phaarmasia | 13.90 | -31849.18 | -99.96 | 19.11 |
| Denis Chem Lab | 33.05 | -31830.03 | -99.90 | 124.12 |
| Shukra Pharma. | 36.20 | -31826.88 | -99.89 | 5.66 |
| TTK Healthcare | 451.00 | -31412.08 | -98.58 | 627.88 |
| Panch.Organics | 49.40 | -31813.68 | -99.84 | 48.23 |
| Proc. Gam. Heal. | 4159.20 | -27703.88 | -86.95 | 848.99 |
| Ind-Swift | 2.75 | -31860.33 | -99.99 | 289.03 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
